Filing Details

Accession Number:
0001232524-14-000140
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-10 17:48:18
Reporting Period:
2014-11-06
Filing Date:
2014-11-10
Accepted Time:
2014-11-10 17:48:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1267490 J Karen Wilson C/O Jazz Pharmaceuticals Plc
Connaught House, 1 Burlington Rd, Fl. 4
Dublin 4 L2
Svp, Finance & Pao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-11-06 5,000 $46.83 26,713 No 4 M Direct
Ordinary Shares Acquisiton 2014-11-06 2,000 $59.13 28,713 No 4 M Direct
Ordinary Shares Disposition 2014-11-06 7,000 $170.12 21,713 No 4 S Direct
Ordinary Shares Disposition 2014-11-06 596 $170.00 21,117 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Nonstatutory Stock Option (right to buy) Disposition 2014-11-06 5,000 $0.00 5,000 $46.83
Ordinary Shares Nonstatutory Stock Option (right to buy) Disposition 2014-11-06 2,000 $0.00 2,000 $59.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,702 2022-08-08 No 4 M Direct
6,250 2023-03-04 No 4 M Direct
Footnotes
  1. As of the date of this report, the remaining ordinary shares subject to this option are vested with respect to 625 shares and will vest with respect to 625 shares on December 9, 2014, with respect to 6,587 shares in equal monthly installments from January 9, 2015 to December 9, 2015 and with respect to 2,865 shares in equal monthly installments from January 9, 2016 to August 9, 2016.
  2. As of the date of this report, the remaining ordinary shares subject to this option will vest with respect to 250 shares on December 5, 2014 and with respect to 6,000 shares in equal monthly installments from January 5, 2015 to December 5, 2016.